US Recall News

United States Recall News Alerts for Recalled Drugs, Food, Products, & Vehicles

MENUMENU
  • Home
  • About
    • Advertise
  • Full Recall News Archive
    • Top Story

      J&J Settles Talc Mesothelioma Settlement

      By Sandra Dalton, Staff Writer On January 6, 2020, Superior Court Judge Stephen Kaus announced that Johnson & Johnsons (J&J) had agreed to … [Read More...]

      Winston Products Recalls 5/8-Inch HydroTech Expandable Burst-Proof Hoses Due to Risk of Impact Hazard and Temporarily Impaired Hearing

      The recalled hoses can burst, posing an impact hazard and a risk of temporarily impaired hearing. … [Read More...]

    • More Safety Articles
    • Federal Preemption of State Product Liability Law
  • Drug Recalls
    • Abilify
    • Benicar
    • Fluoroquinolones
    • Invokana
    • Lipitor
    • Nuplazid
    • Opioids
    • OxyContin
    • Pradaxa
    • Proton Pump Inhibitors (PPIs)
    • Risperdal
    • SSRI
    • Symptoms & Side Effects
    • Taxotere
    • Testosterone
    • Uloric
    • Valsartan
    • Xarelto
    • Zofran
  • Medical Devices
    • 3M Earplug
    • 3T Heater-Cooler System
    • Bair Hugger
    • Bipolar Hip System
    • Essure
    • Hip Replacements
    • Implanon
    • IVC Filters
    • Hernia Mesh
    • Power Morcellators
    • Shoulder Implants
    • Transvaginal Mesh
  • Food Recalls
    • FDA Press Releases
    • USDA Press Releases
  • Auto Recalls
    • Air Bags
    • Ignitions
    • NHTSA Press Releases
    • Off-Road Utility Vehicles
    • Snowmobiles
    • Tires
  • Other Products
    • Asbestos
    • Baby Products
    • Pet Products
    • Roundup
    • Talcum Powder
    • Toy Recalls
You are here: Home / Food Recalls / FDA Press Releases / Amneal Pharmaceuticals Issues Voluntary Nationwide Recall of Lorazepam Oral Concentrate, USP 2mg/mL, Due to Misprinted Dosing Droppers Supplied with the Product

Amneal Pharmaceuticals Issues Voluntary Nationwide Recall of Lorazepam Oral Concentrate, USP 2mg/mL, Due to Misprinted Dosing Droppers Supplied with the Product

August 16, 2017 By The FDA Leave a Comment

Amneal Pharmaceuticals LLC is voluntarily recalling 13 lots of Lorazepam Oral Concentrate, USP 2mg/mL, to the Consumer level due to a defect in the dropper markings. The Lorazepam Oral Concentrate, USP 2mg/mL, product is packaged with a dosing dropper, supplied to Amneal by a third party. In a few instances, the dropper is printed with the dose markings in reverse number order, has no dose markings or has dose markings that are shifted. Amneal learned about the issue from a Consumer’s report. To date no adverse events related to these dropper defects have been reported to Amneal. The below picture shows examples of a dropper with the correct print, along with examples of droppers with the defects.

Risk Statement: There is a significant likelihood that the dropper marking errors will result in dispensing either less than, or more than, the prescribed dose. There is a significant probability of a serious health consequence if more than the prescribed dose is dispensed and potential serious adverse events include – drowsiness causing trauma; increased anxiety; increased accidental injury to self or others (e.g., hip fracture, motor vehicle accident); which in the most serious circumstances could result in permanent decreased function or death.

The product is indicated for the management of anxiety disorders for the short-term relief of the symptoms of anxiety or anxiety associated with depressive symptoms. It is packaged in an individual carton, identified with the code: NDC 65162-687-84, which contains a 30mL amber glass bottle of liquid produced by Amneal, a package insert with patient information, and a plastic dropper sealed in a clear plastic bag. The affected Lorazepam Oral Concentrate, USP 2mg/mL, lots are the following:

Lot Number Expiration Date
06876016A 08/2018
06876017A 08/2018
06876018A 08/2018
06876019A 09/2018
06876020A 09/2018
06876021A 09/2018
06876022A 09/2018
06876023A 11/2018
06876024A 12/2018
06876025A 12/2018
06877001A 02/2019
06877002A 02/2019
06877003A 03/2019

The product can be identified by the lot number printed on the bottom-right side of the blue and white label, with the Amneal logo, on the amber bottle supplied with the dropper, in a blue and white carton, with the Amneal logo. The Lorazepam Oral Concentrate, USP 2mg/mL was distributed nationwide to wholesalers.

Amneal Pharmaceuticals has notified its wholesale customers by a Recall Letter to return all recalled lots. Amneal is notifying pharmacies by providing a Recall Letter and a supply of replacement droppers to all pharmacies that may have received any of the recalled lots. There is no safety issue with the bottled product itself. To avoid any interruption in supply or access to the medication by the patient, pharmacies are instructed to immediately discard the dropper included with the recalled lots and replace it with the dropper included with the Recall Letter. Amneal also is providing the pharmacist with a sticker which the pharmacist is required to place on the box to alert the patient and other pharmacists that the dropper has been replaced. Pharmacists are instructed to notify all Consumers impacted by the recall of the potential defect and the need to exchange a defective dropper. Consumers are instructed to discontinue use of any defective dropper and return it to the place of purchase for a replacement. If Consumers are unsure whether their droppers are defective they are encouraged to confirm with their dispensing pharmacy.

Consumers with questions regarding this recall can contact Amneal Pharmaceuticals at 631.952.0214 x338 or amnealreg@amneal.com on Monday through Friday from 9AM through 5PM Eastern Time. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail, or by fax.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

About Amneal:

Amneal Pharmaceuticals LLC, a privately-held, global, company headquartered in Bridgewater, New Jersey, was founded in 2002 and is one of the largest and fastest growing generic pharmaceutical manufacturers in the United States.

Click here to view full prescribing information for Lorazepam Oral Concentrate.disclaimer icon

###

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Related

Filed Under: FDA Press Releases

About The FDA

The Food and Drug Administration (FDA) is an agency within the U.S. Department of Health and Human Services. It consists of the Office of the Commissioner and four directorates overseeing the core functions of the agency: Medical Products and Tobacco, Foods and Veterinary Medicine, Global Regulatory Operations and Policy, and Operations.

Leave a ReplyCancel reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Facebook
Thomas Roney LLC
Economic Consulting

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

Winston Products Recalls 5/8-Inch HydroTech Expandable Burst-Proof Hoses Due to Risk of Impact Hazard and Temporarily Impaired Hearing

July 23, 2025 By The CPSC

Curtis International Recalls Frigidaire-brand Minifridges Due to Fire and Burn Hazards; More Than $700,000 Reported in Property Damage

July 23, 2025 By The CPSC

Pura Scents Recalls Detachable Covers of Smart Home Fragrance Diffusers Due to Magnet Ingestion Hazard

July 23, 2025 By The CPSC

Hero Highlight

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

LED Gloves Recalled Due to Risk of Serious Injury or Death from Battery Ingestion; Violates the Mandatory Toy Standard and Child Resistant Coin Battery Packaging Standard; Sold on Amazon by Minongad

July 23, 2025 By The CPSC

Diamond G Forest Products Recalls Turpentine Bottles Due to Risk of Serious Injury or Death from Child Poisoning; Violates Mandatory Standard for Child Resistant Packaging

July 23, 2025 By The CPSC

Innovative Designs Recalls Minecraft Light-Up Slap Ruler Bracelets Due to Risk of Serious Injury or Death from Button Cell Battery Ingestion Hazard; Violates Mandatory Standard for Toys

July 23, 2025 By The CPSC

Creekwood Naturals Recalls 100% Natural Pure Gum Spirits of Turpentine Bottles Due to Risk of Serious Injury or Death from Child Poisoning; Violates Mandatory Standard for Child Resistant Packaging

July 23, 2025 By The CPSC

FENGQS Electric Bikes Recalled Due to Fire and Burn Hazards; Risk of Serious Injury or Death; Sold on Amazon

July 23, 2025 By The CPSC

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

Creekwood Naturals Recalls 100% Natural Pure Gum Spirits of Turpentine Bottles Due to Risk of Serious Injury or Death from Child Poisoning; Violates Mandatory Standard for Child Resistant Packaging

July 23, 2025 By The CPSC

FENGQS Electric Bikes Recalled Due to Fire and Burn Hazards; Risk of Serious Injury or Death; Sold on Amazon

July 23, 2025 By The CPSC

Aiho Dressers Recalled Due to Risk of Serious Injury or Death from Tip-Over and Entrapment; Violates Mandatory Standard; Sold on Walmart.com by Aiho

July 23, 2025 By The CPSC

Recall News in Your Inbox

Enter your email address to receive automated recall news updates.

Recent Comments

  • Roger McGowan on ABH NATURE’S PRODUCTS, INC, ABH PHARMA, INC., and STOCKNUTRA.COM, INC. Issues Nationwide Recall of All Lots of Dietary Supplement Products
  • Kathryn Moore on FDA Wants Cancer Warning on Breast Implants
  • BRAD on Huge ATV Recall by Polaris – Sportsman and Scrambler
  • Crystal Anderson on Allergan Voluntarily Recalls BIOCELL® Textured Breast Implants and Tissue Expanders
  • Outsourcing Training on The Modern Marketing of Pain
  • SANDRA Collett on Processed Food Preservative Linked to Autism?
  • Eric Karsh on Health Risks of Roundup Go Well Beyond Cancer

Recent Posts

  • Winston Products Recalls 5/8-Inch HydroTech Expandable Burst-Proof Hoses Due to Risk of Impact Hazard and Temporarily Impaired Hearing
  • Curtis International Recalls Frigidaire-brand Minifridges Due to Fire and Burn Hazards; More Than $700,000 Reported in Property Damage
  • Pura Scents Recalls Detachable Covers of Smart Home Fragrance Diffusers Due to Magnet Ingestion Hazard
  • iMirror Inc. Recalls Electric Bug Zapper Racket, Fly Swatter, and Mosquito Swatter Due to Shock Hazard
  • Transpro US Recalls Electric Scooters with Unauthorized Lithium-Ion Battery UL Certification Labels Due to Fire and Burn Hazards; Risk of Serious Injury and Death; $200,000 in Property Damage Reported
  • LED Gloves Recalled Due to Risk of Serious Injury or Death from Battery Ingestion; Violates the Mandatory Toy Standard and Child Resistant Coin Battery Packaging Standard; Sold on Amazon by Minongad
  • Diamond G Forest Products Recalls Turpentine Bottles Due to Risk of Serious Injury or Death from Child Poisoning; Violates Mandatory Standard for Child Resistant Packaging
  • Innovative Designs Recalls Minecraft Light-Up Slap Ruler Bracelets Due to Risk of Serious Injury or Death from Button Cell Battery Ingestion Hazard; Violates Mandatory Standard for Toys
  • Creekwood Naturals Recalls 100% Natural Pure Gum Spirits of Turpentine Bottles Due to Risk of Serious Injury or Death from Child Poisoning; Violates Mandatory Standard for Child Resistant Packaging
-- See More Recall News

Disclaimer: The information contained in these topics is not intended nor implied to be a substitute for professional medical or legal advice, it is provided for educational purposes only. Always seek the advice of your physician or other qualified healthcare provider about any questions you may have regarding a medical condition. Nothing contained in these topics is intended to be used for medical diagnosis or treatment.


ATTORNEY ADVERTISING. The information provided on this website is not legal advice. No attorney-client relationship is formed by the use of this site. It is not stated or implied that a lawyer is certified as a specialist in any particular field of law. No results are guaranteed, and prior results do not guarantee a similar outcome. This site is informational, only, not dispositive; it is up to you to decide whether a particular lawyer is right for you. Use of this site is subject to your agreement to these.


Copyright © 2025 Altrumedia · Terms of Service · Log in